萊美藥業(300006.SZ):股東邱煒所持2147萬股司法拍賣股份流拍
格隆匯6月1日丨萊美藥業(300006.SZ)公佈,公司於2020年4月30日在巨潮資訊網上披露了《關於持股5%以上股東所持公司部分股份擬被司法拍賣暨被動減持的預披露公告》,公司股東邱煒合計持有公司股票2147萬股(佔公司總股本的2.64%)將於2020年5月30日10時至2020年5月31日10時(延時的除外)在“京東網”(網址:www.jd.com)公開拍賣,根據京東網司法拍賣網絡平台頁面顯示的拍賣結果,首輪拍賣流拍。
截止公告披露日,邱煒持有公司股份約2937.00萬股,佔公司總股本的3.62%。上述司法拍賣的公司股份數量為2147萬股,佔公司總股本的2.64%。邱煒所持公司股份已全部被司法凍結。上述司法拍賣的公司股份可能存在第二輪司法拍賣以及流拍後被司法劃轉的相關風險。
.
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.